Aquestive Therapeutics Files Routine 8-K
Ticker: AQST · Form: 8-K · Filed: Jul 15, 2025 · CIK: 1398733
| Field | Detail |
|---|---|
| Company | Aquestive Therapeutics, Inc. (AQST) |
| Form Type | 8-K |
| Filed Date | Jul 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-K
Related Tickers: AQST
TL;DR
AQST filed a standard 8-K, no major news yet.
AI Summary
Aquestive Therapeutics, Inc. filed an 8-K on July 15, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material agreements, but rather serves as a routine update and filing of exhibits.
Why It Matters
This filing indicates Aquestive Therapeutics is meeting its regulatory reporting obligations. Investors should look for more detailed filings to understand significant business developments.
Risk Assessment
Risk Level: low — This is a routine filing with no new material information that would immediately impact the company's risk profile.
Key Players & Entities
- Aquestive Therapeutics, Inc. (company) — Registrant
- July 15, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 30 Technology Drive Warren, NJ 07059 (address) — Principal Executive Offices
- MonoSol Rx, Inc. (company) — Former company name
FAQ
What specific "Other Events" are being reported in this 8-K?
The filing indicates "Other Events" as an item information, but the provided text does not detail what those specific events are.
What "Financial Statements and Exhibits" are included with this filing?
The filing lists "Financial Statements and Exhibits" as an item information, but the specific contents of these exhibits are not detailed in the provided text.
When was Aquestive Therapeutics, Inc. incorporated?
Aquestive Therapeutics, Inc. was incorporated in Delaware.
What is the principal executive office address for Aquestive Therapeutics, Inc.?
The principal executive office address is 30 Technology Drive, Warren, NJ 07059.
What was the former name of Aquestive Therapeutics, Inc.?
The former name of Aquestive Therapeutics, Inc. was MonoSol Rx, Inc.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 15, 2025 regarding Aquestive Therapeutics, Inc. (AQST).